Average Co-Inventor Count = 3.83
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (45 from 2,405 patents)
2. Merck + Co., Inc. (27 from 4,770 patents)
3. Cytomed, Inc. (6 from 17 patents)
4. Ucb S.a. (2 from 119 patents)
5. Millennium Pharmaceuticals Limited (1 from 850 patents)
6. Merial Limited (1 from 320 patents)
7. Merck Sharpe & Dohme Corp. (1 from 35 patents)
8. Kallyope, Inc. (1 from 6 patents)
9. Merck Shapr & Dohme Corp. (1 from 1 patent)
84 patents:
1. 12281114 - NK3 modulators and uses thereof
2. D1022708 - Bottle
3. 11433055 - Chromane monobactam compounds for the treatment of bacterial infections
4. 11230543 - Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
5. 10519115 - Antidiabetic tricyclic compounds
6. 10442819 - Tricyclic compounds as inhibitors of mutant IDH enzymes
7. 10399972 - Tricyclic compounds as inhibitors of mutant IDH enzymes
8. 10000454 - Antidiabetic tricyclic compounds
9. 9932311 - Antidiabetic tricyclic compounds
10. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
11. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
12. 9540364 - Benzimidazole tetrahydrofuran derivatives
13. 9527839 - Benzimidazole tetrahydropyran derivatives
14. 9469608 - Thrombin inhibitors
15. 9447085 - Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use